Understanding How Adults Learn

The Key to Reducing Deviations, Delays, and Product Loss in Pharmaceutical Manufacturing

“Kids are like sponges!” This is a comment we have all heard about how quickly kids pick up and internalize learning. Words, concepts, and language all seem to be easily absorbed and retained by children of all ages. Then we grow up and suddenly just remembering where the car keys are located becomes a challenge.

I had intended to quote several neuroscientists about the differences between kids and adults, but if you are over 25 and have attempted to learn a new skill or language, you understand the challenges of adult learning. Becoming proficient at something new requires focus, repetitive practice, and sufficient time to absorb and retain the details. Not rocket science, but we in the pharmaceutical and biopharmaceutical industries apparently think the people who work for us are different. We cram training into short segments or only when production schedules allow. We ask our people to ‘read and understand’ procedures which sometimes exceed 30 pages in length. Then we give them a chance to observe a trained technician, perform the skill a few times under supervision, and then become responsible for activities that are critical to the quality of the drugs they are manufacturing.

Despite these approaches, which any educator or trainer will confirm are minimally effective, senior management is surprised when errors occur that result in deviations, delays or, all too often, product rejection. To further compound the problem, the resulting investigation and corrective action often focuses on “retraining” the technician.

In recent blogs and a fine article in the European Journal of Parenteral and Pharmaceutical Sciences, my colleague Tyler DeWitt has discussed the value of utilizing virtual reality as a training tool coupled with video lectures that allow the student to learn the fundamentals at their own pace, review critical knowledge as frequently as needed to internalize the information, and then practice in a safe environment the physical manipulations required.

In addition to incorporating state-of-the-art education tools and methods, we need to create an environment in our operations that recognizes how adults learn and how they maintain proficiency over time. Successful, consistent, and sustainable production requires well-trained and educated technicians, supervisors, and quality partners. Achieving this level of performance requires that several key elements be incorporated into the manufacturing culture.

-Training and education are not a supplemental activity. For new skills, the individual must be given sufficient time to learn, practice, and then demonstrate the skill. For experienced personnel, regular refresher sessions are essential.

-Curricula must be focused and targeted to the task. With today’s learning and education tracking software, it is too easy to dump courses and tasks into an individual’s requirements without regard to the benefit it provides in doing the role successfully.

-Roles and responsibilities must be clearly defined to keep skill development focused and effective. Often in the name of flexibility, we train our personnel to perform multiple tasks and the result is poor execution due to insufficient practice or too many tasks to master successfully.

-Knowledge Management is a key role in pharmaceutical and biopharmaceutical manufacturing operations. A person or group must bet asked with ensuring that the production team is trained and educated to perform optimally. This requires monitoring performance and performing continuous improvement on the curricula, methods, and material utilized for skill development and sustainability. It is not the administrative function of maintaining training records.

If we look outside our industry, there are numerous examples of critical jobs (e.g., airline pilots)or even sports teams that understand and apply these principles to develop and maintain optimal performance. We all understand in our industry that our patients rely on us to provide them with effective, high-quality pharmaceuticals. Recent news reports, such as “Drug Shortages Near All-Time High, Leading to Rationing”(1) demonstrate that we are not meeting that challenge. Changing our approach to training and education can be an important part of resolving this problem.

(1) Drug Shortages Near All-Time High, Leading to Rationing by Christina Jewett, New York Times, May 18, 2023


QxP Vice President Mike Levitt started his more than 30-year career in pharma leadership as Director of Production Operations at Eli Lilly and Company back in 1989.

Check out Mike’s other recent blog, “Six Keys for Effective Deviation Investigators.

 

Quality Executive Partners - IACET Accreditation

Ken Mead
April 9, 2024

Coaching and Correcting: A Focus on Behavior Over Blame

Sarah Boynton
November 1, 2023

The Importance of Roles and Responsibilities in Biotech Manufacturing & Human Error Prevention

Sarah Boynton
October 26, 2023

Remote cGMP Inspections and AI in Drug Manufacturing

Michelle Fishburne
October 11, 2023

4 Best Practices for Effective Investigation into Deviations

Sarah Boynton
September 19, 2023

The Art of Viral Vector Manufacturing: 4 Essential Controls to Prevent Cross-Contamination

Sarah Boynton
September 13, 2023

Practicing Risk Acceptance

Mark Roache
August 28, 2023

Annex 1 – Can we all take a deep breath now?

Vanessa Figueroa
August 24, 2023

In Cell and Gene, Good Science is Necessary, But Not Sufficient

Mark Roache
August 21, 2023

6 Ways To Achieve Manufacturing Audit And Inspection Readiness

Sarah Boynton
August 14, 2023

Experience is What You Get Just After You Needed It, Part 2

Mark Roache
August 10, 2023

Experience is What You Get Just After You Needed It, Part 1

Mark Roache
August 10, 2023

Sterility Assurance Matters to This ONE

Greg Gibb
August 8, 2023

Enhancing Quality and Safety: 3 Essential Human Error Prevention Tools for cGMP Manufacturing

Sarah Boynton
August 3, 2023

Asia-Pacific Happenings: Samsung Bioepis Implements QxP Virtuosi®

Michelle Fishburne
August 2, 2023

CDMOs – Selecting the Right One for Each Manufacturing Stage

Christine Feaster
July 24, 2023

3 Types of Human Error and Potential CAPAs to Prevent Them

Sarah Boynton
July 20, 2023

Drug Shortages: Causes & Solutions

Christine Feaster
July 10, 2023

The 5 Questions You Need to Ask After a Human Error Event Occurs

Sarah Boynton
July 5, 2023

Annex 1 and Ensuring Filling Technologies Fit the Need

Natasha Howard
June 21, 2023

How to Solve Pharma’s Skilled Workforce Deficit

Jeff Roy
June 20, 2023

ChatGPT Told Me AI is “Imperative” in Pharma Manufacturing

No items found.
June 18, 2023

Get Ready: FDORA’s Unannounced Foreign Inspection Pilot Program is On!

Crystal Mersh
June 6, 2023

Nitrosamines Impurity Challenges

Christine Feaster
June 2, 2023

All You Need to Know About Contamination Control Strategies, Parts 1 and 2

No items found.
June 1, 2023

When is ISO 8 Not ISO 8?

Bob Ferer
May 30, 2023

Cost Of Quality: Worth Every Cent In Bio/Pharmaceutical Manufacturing

Crystal Mersh
May 24, 2023

Pharmaceutical Quality is NOT a Spectator Sport

Mike Levitt
May 22, 2023

The Six Keys for Effective Deviation Investigators

Mike Levitt
May 18, 2023

There Has to be a Better Way to Train

Tyler DeWitt, Ph.D.
May 15, 2023

Cell and Gene: Article Series on CGT’s Key Drivers

Mark Roache
May 8, 2023

Bacterial Endotoxin Testing is on the Move

Christine Feaster
May 5, 2023

Top 20 Pharma Company Chooses QxP Virtuosi® Platform

Vanessa Figueroa
May 3, 2023

Crystal Clear: Controls Are Not Enough

Crystal Mersh
April 22, 2023

Myth #1: Complying with Regulations and Product Specifications

Brian Duncan
April 20, 2023

Myth #2: Proactively Remediating Bad Inspection Outcomes: What’s the benefit?

Brian Duncan
April 20, 2023

Is it Time to Outsource Internal Auditing?

Mike Levitt
April 18, 2023

Quality is Number One, Even When Trying to Address Supply Chain Issues

Christine Feaster
April 14, 2023

Don’t Be a Daredevil When Retrofitting Your Facility, Part 2

Bob Ferer
April 10, 2023

Don’t Be a Daredevil When Retrofitting Your Facility, Part 1

Bob Ferer
April 10, 2023